Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000104

Chief Business Officer gave up 1,102 shares (to pay taxes)

  • Chief Business Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Boyle Scott N Chief Business Officer 2024-11-07 Option exercise +3,750 57,669 D
Boyle Scott N Chief Business Officer 2024-11-07 Shares withheld for taxes −1,102 $6.04 $6,656 56,567 D
Derivatives
Boyle Scott N Chief Business Officer 2024-11-07 Option exercise · Performance Restricted Stock Units −3,750 10,500 D
Loading xslF345X05/wk-form4_1731446256.xml…